Actively Recruiting
Improving Care for Adults with Breast, Gastrointestinal, or Hematologic Cancer and Other Health Conditions Using a Shared Care Model Between Oncologists and Primary Care Providers
Led by Baylor College of Medicine · Updated on 2026-06-30
340
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Cancer survivors with additional chronic health conditions often face complex healthcare challenges, especially those from underserved communities who may have limited access to supportive care. This research evaluates a shared care model called OPTIMISE, designed to improve communication and coordination between oncologists and primary care providers for newly diagnosed breast, gastrointestinal, and hematologic cancer patients with comorbidities. The study compares OPTIMISE with usual medical care to understand its impact on patient self-management, quality of life, healthcare use, and provider attitudes. Participants are randomly assigned to either the OPTIMISE group or usual medical care. OPTIMISE involves a bilingual oncology nurse navigator who coordinates care, distress screening, culturally tailored self-management action plans, structured communication between oncologists and primary care providers, and a risk-stratified shared care model that adjusts surveillance visits between oncologists and primary care providers. Usual care includes standard oncologic treatment, survivorship care planning, and oncologist-led surveillance visits. The study collects data through surveys at multiple time points from diagnosis through post-treatment survivorship. Throughout the study, participants complete surveys at baseline, during treatment, at survivorship care plan delivery, and up to 12 months after. The nurse navigator supports patients by facilitating referrals, providing resources, and following up on self-management goals. Researchers assess patient activation for managing chronic conditions, quality of life, and care coordination between providers. Interviews with patients and providers help identify barriers and opportunities for improving care transitions. The total study duration includes active treatment and one year of post-treatment follow-up.
CONDITIONS
Brief Title
Improving Comprehensive Care of Cancer Patients
Research Team
H
Hoda J. Badr, PhD
A
Aylin Diaz-Valladares, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here